UGT2B7

Across TCGA pan-cancer cohorts, UGT2B7 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated UGT2B7 data layer compared with 23 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher UGT2B7 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated UGT2B7 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and PDAC show a favorable association.

CCRCC and PDAC are the cancer types where UGT2B7 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Median	All	0.943	0.742	<.001	49	view →
PDAC	DFS	Quartile	II,III,IV	0.959	0.591	.003	37	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

UGT2B7–CCRCC (OS)

Open the CCRCC breakdown →